Prolonged therapy with low-molecular-weight heparin after PCI.
Zidar
J P
JP
Duke University Medical Center, Box 3290, Durham, NC 27710, USA.
D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D006328:Cardiac Catheterization / Q000379:methods; D003131:Combined Modality Therapy; D017023:Coronary Angiography / Q000379:methods; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D015150:Echocardiography, Doppler; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D008134:Long-Term Care; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000628:therapy*; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D015607:Stents; D013923:Thromboembolism / Q000517:prevention & control; D016896:Treatment Outcome; D014654:Vascular Patency / Q000502:physiology
D006495:Heparin, Low-Molecular-Weight